Haven't PR and Beverly been talking about "deals" the last year and a half? I believe one was suppose to occur by Q2 2024. Not one deal has yet to materialize.
LiveStream: Paradigm Biopharma (ASX:PAR) pursuing FDA review, page-11
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
28.5¢ |
Change
-0.005(1.72%) |
Mkt cap ! $110.9M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 29.5¢ | 28.5¢ | $9.663K | 33.63K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 85501 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 21768 | 5 |
View Market Depth
| Last trade - 10.45am 16/06/2025 (20 minute delay) ? |
| PAR (ASX) Chart |